BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35110468)

  • 1. A Pre-clinical Trial Study: Anti-human Colon Cancer Effect of Thalassiolin B in vitro with Enzymes Inhibition Effects and Molecular Docking Studies.
    Li Y; Cheng R; Zou S; Zhang Y; Alotaibi SH; Xu L
    J Oleo Sci; 2022; 71(2):267-276. PubMed ID: 35110468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of Diosmin to Control Diabetes and Its Complications-an In Vitro and In Silico Approach.
    Dubey K; Dubey R; Gupta R; Gupta A
    Curr Comput Aided Drug Des; 2021; 17(2):307-313. PubMed ID: 32208122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structures required of flavonoids for inhibiting digestive enzymes.
    Cao H; Chen X
    Anticancer Agents Med Chem; 2012 Oct; 12(8):929-39. PubMed ID: 22292767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The multi-targets integrated fingerprinting for screening anti-diabetic compounds from a Chinese medicine Jinqi Jiangtang Tablet.
    Chang YX; Ge AH; Donnapee S; Li J; Bai Y; Liu J; He J; Yang X; Song LJ; Zhang BL; Gao XM
    J Ethnopharmacol; 2015 Apr; 164():210-22. PubMed ID: 25698248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of α-glucosidase and α-amylase by herbal compounds for the treatment of type 2 diabetes: A validation of in silico reverse docking with in vitro enzyme assays.
    Tolmie M; Bester MJ; Apostolides Z
    J Diabetes; 2021 Oct; 13(10):779-791. PubMed ID: 33550683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target guided isolation, in-vitro antidiabetic, antioxidant activity and molecular docking studies of some flavonoids from Albizzia Lebbeck Benth. bark.
    Ahmed D; Kumar V; Sharma M; Verma A
    BMC Complement Altern Med; 2014 May; 14():155. PubMed ID: 24886138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the Anti-Breast Cancer Effects of Urolithin with Molecular Docking Studies in the In Vitro Condition: Introducing a Novel Chemotherapeutic Drug.
    Han L; Zhao D; Li Y; Jin J; El-Kott AF; Al-Saeed FA; Eldib AM
    Mol Biotechnol; 2024 Mar; 66(3):554-566. PubMed ID: 37280483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Silico Studies, Anti-oxidant Properties, Antisorbitol Dehydrogenase, Anti-alpha Amylase and Anti-gastrointestinal Cancer Potential of Violanthin as a Natural Compound.
    Zhong Z; Chen Z; Liu J; Hirad AH; Sun J
    J Oleo Sci; 2023; 72(11):1015-1026. PubMed ID: 37914263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological evaluation the 2-aryl-2,3-dihydrobenzodiazaborinin-4(1H)-ones as potential dual α-glucosidase and α-amylase inhibitors with antioxidant properties.
    Mphahlele MJ; Magwaza NM; Malindisa ST; Choong YS
    Chem Biol Drug Des; 2021 Aug; 98(2):234-247. PubMed ID: 34013660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening alpha-glucosidase and alpha-amylase inhibitors from natural compounds by molecular docking in silico.
    Jhong CH; Riyaphan J; Lin SH; Chia YC; Weng CF
    Biofactors; 2015; 41(4):242-51. PubMed ID: 26154585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-Amylase and Alpha-Glucosidase Enzyme Inhibition and Antioxidant Potential of 3-Oxolupenal and Katononic Acid Isolated from
    Alqahtani AS; Hidayathulla S; Rehman MT; ElGamal AA; Al-Massarani S; Razmovski-Naumovski V; Alqahtani MS; El Dib RA; AlAjmi MF
    Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31905962
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and molecular docking studies of imines as α-glucosidase and α-amylase inhibitors.
    Aispuro-Pérez A; López-Ávalos J; García-Páez F; Montes-Avila J; Picos-Corrales LA; Ochoa-Terán A; Bastidas P; Montaño S; Calderón-Zamora L; Osuna-Martínez U; Sarmiento-Sánchez JI
    Bioorg Chem; 2020 Jan; 94():103491. PubMed ID: 31818480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel cinnamic acid magnolol derivatives as potent α-glucosidase and α-amylase inhibitors: Synthesis, in vitro and in silico studies.
    Hu CM; Wang WJ; Ye YN; Kang Y; Lin J; Wu PP; Li DL; Bai LP; Xu XT; Li BQ; Zhang K
    Bioorg Chem; 2021 Nov; 116():105291. PubMed ID: 34438122
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Das SK; Dash S; Thatoi H; Patra JK
    Comb Chem High Throughput Screen; 2020; 23(9):945-954. PubMed ID: 32342807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural Triterpenoids Isolated from Akebia trifoliata Stem Explants Exert a Hypoglycemic Effect via α-Glucosidase Inhibition and Glucose Uptake Stimulation in Insulin-Resistant HepG2 Cells.
    Bian G; Yang J; Elango J; Wu W; Bao B; Bao C
    Chem Biodivers; 2021 May; 18(5):e2001030. PubMed ID: 33779055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Evaluation of the Anti-Diabetic Potential of Aqueous Acetone
    Akinyede KA; Oyewusi HA; Hughes GD; Ekpo OE; Oguntibeju OO
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of azachalcones, their α-amylase, α-glucosidase inhibitory activities, kinetics, and molecular docking studies.
    Saleem F; Kanwal ; Khan KM; Chigurupati S; Solangi M; Nemala AR; Mushtaq M; Ul-Haq Z; Taha M; Perveen S
    Bioorg Chem; 2021 Jan; 106():104489. PubMed ID: 33272713
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Osman W; Ismail EMOA; Shantier SW; Mohammed MS; Mothana RA; Muddathir A; Khalid HS
    J Recept Signal Transduct Res; 2021 Apr; 41(2):159-169. PubMed ID: 32718219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural flavonoid α-glucosidase inhibitors from Retama raetam: Enzyme inhibition and molecular docking reveal important interactions with the enzyme active site.
    Ghani U; Nur-E-Alam M; Yousaf M; Ul-Haq Z; Noman OM; Al-Rehaily AJ
    Bioorg Chem; 2019 Jun; 87():736-742. PubMed ID: 30954838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidiabetic potential: In vitro inhibition effects of bromophenol and diarylmethanones derivatives on metabolic enzymes.
    Demir Y; Taslimi P; Ozaslan MS; Oztaskin N; Çetinkaya Y; Gulçin İ; Beydemir Ş; Goksu S
    Arch Pharm (Weinheim); 2018 Dec; 351(12):e1800263. PubMed ID: 30478943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.